Human | UCA1 | 652995 | urothelial cancer associated 1 (non-protein coding) | Results from the present study suggested that UCA1 might play a pivotal role in bladder cancer progression and embryonic development |
Human | H19 | 283120 | H19, imprinted maternally expressed transcript (non-protein coding) | analysis of IGF2 and H19 loss of imprinting in bladder cancer |
Human | NEWENTRY | 192343 | Record to support submission of GeneRIFs for a gene not in Gene (human; man). | NMP22, nuclear matrix protein-22 in urine may be promising tool for screening bladder cancer [NMP22] |
Human | NRG4 | 145957 | neuregulin 4 | Neuregulin-4 expression is downregulated during urinary bladder cancer progression |
Human | PIGU | 128869 | phosphatidylinositol glycan anchor biosynthesis, class U | CDC91L1 is an oncogene in bladder cancer, and implicate the GPI anchoring system as a potential oncogenic pathway and therapeutic target in human cancers |
Human | COL18A1 | 80781 | collagen, type XVIII, alpha 1 | Lentivirus-mediated gene transfer might represent an effective strategy for expression of angioinhibitory peptides to achieve inhibition of human bladder cancer proliferation and tumor progression |
Human | TSGA10 | 80705 | testis specific, 10 | over-expressed in 4 of 20 hepatocellular carcinomas (HCC), 1 of 20 colon cancers, 7 of 20 ovarian cancers, 3 of 20 prostate cancers, 1 of 21 malignant melanomas, and 8 of 21 bladder cancers |
Human | ZDHHC11 | 79844 | zinc finger, DHHC-type containing 11 | data suggest that gain of 5p15.33 (TPPP and ZDHHC11) may become a potential biomarker identifying high-risk patients with disease progression in bladder cancer |
Human | BIRC7 | 79444 | baculoviral IAP repeat containing 7 | Livin expression may have a role in the development of bladder cancer |
Human | CSMD1 | 64478 | CUB and Sushi multiple domains 1 | BAC microarray-CGH detects homozygous deletion of CSMD1 in human bladder cancer specimens |
Human | GNB4 | 59345 | guanine nucleotide binding protein (G protein), beta polypeptide 4 | Intron-1 haplotypes of GNB4 may, thus, serve as predictive markers for progression and survival of patients suffering from bladder cancer |
Human | DLL4 | 54567 | delta-like 4 (Drosophila) | DLL4 expression is associated with vascular differentiation in bladder cancer |
Human | KRT20 | 54474 | keratin 20 | The diagnostic efficacy of urinary CD44 and cytokeratin 20 (CK20) mRNA in comparison with voided urine cytology (VUC) for the detection of bladder cancer, was evaluated Dysregulation of CK20 expression is an early event in the carcinogenesis of papillary noninvasive bladder cancer |
Human | WWOX | 51741 | WW domain containing oxidoreductase | WWOX hypermethylation analys9s could enrich a panel of DNA methylation markers in breast, lung and bladder cancer |
Human | TMEFF2 | 23671 | transmembrane protein with EGF-like and two follistatin-like domains 2 | Methylated PAX6- or TPEF-promoters could represent biomarkers for bladder cancer |
Human | DAPK2 | 23604 | death-associated protein kinase 2 | distinct methylation pattern in bladder cancer with frequent methylation of RARbeta, DAPK, E-cadherin, and p16 |
Human | RHOBTB2 | 23221 | Rho-related BTB domain containing 2 | aberrant methylation in DBC2 promoter may be responsible for the expression loss of DBC2 expression in bladder cancer and this hypermethylation event could play a crucial role in the early stage of bladder tumorigenesis |
Human | PMF1 | 11243 | polyamine-modulated factor 1 | The association of PMF1 methylation with tumor progression and its diagnostic ability using urinary specimens support including PMF1 assessment for the clinical management of bladder cancer patients |
Human | CHEK2 | 11200 | checkpoint kinase 2 | Germline mutations in the CHEK2 kinase gene are associated with bladder cancer |
Human | WIF1 | 11197 | WNT inhibitory factor 1 | Epigenetic inactivation of Wnt inhibitory factor-1 is associated with bladder cancer through aberrant canonical Wnt/beta-catenin signaling pat |
Human | RASSF1 | 11186 | Ras association (RalGDS/AF-6) domain family member 1 | Aberrant methylation of RASSF1A and RARbeta was associated with muscle-invasive and high-grade bladder cancer Frequent hypermethylation of promoter region of RASSF1A in tumor tissues and voided urine of urinary bladder cancer patients RASSF1A promoter methylation is associated with advanced bladder cancer |
Human | HPSE | 10855 | heparanase | expression during the pathogenesis of bladder cancer is due to promoter hypomethylation and transcription factor EGR1 |
Human | POSTN | 10631 | periostin, osteoblast specific factor | loss of WT periostin by down-regulation and/or alternative splicing, which produces Variant I, is closely correlated with the development of bladder cancer Downregulation of periostin is associated with higher grade bladder cancer |
Human | ARL6IP5 | 10550 | ADP-ribosylation-like factor 6 interacting protein 5 | Three novel functional genetic poly- morphisms of JWA gene, -76C, 454A, and 723G, appear to contribute to the etiology of bladder cancer |
Human | MTSS1 | 9788 | metastasis suppressor 1 | Our data indicate that down-regulation of MIM and/or MIM-B expression can occur in bladder cancer cell lines but is not associated with increased invasive behaviour a potential metastasis suppressor gene in bladder cancer; data suggest that it may be involved in cytoskeletal organization |